Macarthur Minerals - Project Manager, Dean Carter
Project Manager, Dean Carter
Source: Macarthur Minerals
  • Macarthur Minerals (MMS) says it’s in “pole position” to become a major iron ore producer with its Lake Giles Iron Project in Western Australia
  • Throughout 2020, the primary focus has been on defining a measured resource for the project, as well as finalising a transport solution to deliver the company’s high-grade magnetite product
  • According to recent data, the Kalgoorlie-Esperance rail network is currently under-utilised, which offers Macarthur the opportunity to make use of the unused capacity
  • With a number of recently completed financings, the company is now looking to formalise infrastructure partner ships for the Lake Giles Project and and begin commercial production of the hematite resource at its Ularring site
  • Macarthur Minerals is currently up 2.08 per cent to C$0.49 per share

Macarthur Minerals (MMS) says it’s in “pole position” to become a major iron ore producer with its Lake Giles Iron Project in Western Australia.

Over the course of this year, the company has been primarily focused on defining a measured resource for the project – which hosts the Ularring and Moonshine resources – along with the completion of the supporting technical report.

A key focus has also been on finalising a transport solution to deliver Macarthur’s high-grade magnetite product to market.

Central to this is the Kalgoorlie-Esperance rail network, which is currently under-utilised compared to earlier run rates, allowing for sufficient capacity to handle the company’s initial yearly output of 3.3 million tonnes of iron ore products.

Current iron ore exports through the Port of Esperance is also below capacity. The 2020 financial year saw just over 7.3 million tonnes shipped, which Macarthur said provides a variety of potential options for rail unloading, storage and ship loading solutions.

“Macarthur is in pole position to move ahead with its Lake Giles Iron Project,” said Joe Phillips, Managing Director of Macarthur Minerals.

“The continued sub-optimal utilisation of regional rail and port infrastructure … means that Macarthur continues to have an historic opportunity not only to bring our high grade magnetite project online, but to become a player in the Yilgarn region in the foreseeable future,” he added.

With a number of recently completed financings, including a A$6.25 million (roughly C$5.92 million) private placement and a A$20 million (C$18.96 million) controlled placement, Macarthur is now looking to achieve a number of key targets over the next 12 months.

These include formalising infrastructure partnerships needed to commercialise the Lake Giles Project, and beginning commercial production at the project’s Ularring resource.

Andrew Bruton, CEO of Macarthur Minerals, noted the determination to accelerate the development of the Lake Giles Project in the near future, adding that 2021 is set to be a “milestone year” for the company.

“Management continues to clinically focus on laying all of the necessary building blocks to deliver the Lake Giles Iron Project, and the company’s appetite to independently accelerate early production of DSO at Ularring has the potential to add material benefit for shareholders and to assist the development and funding of our main high grade magnetite project,” he said.

Macarthur Minerals is currently up 2.08 per cent to C$0.49 per share at 10:05am EST.

More From The Market Online
Stock image generated with AI

@ the Bell: TSX climbs to another new high

Canada’s main stock index reached an all-time high on Thursday, propelled by advances in financial and technology stocks.
Stock image generated with AI

@ the Bell: TSX back to breaking record highs

While the utilities sector led gains on the TSX to its record high, a drop among energy and tech shares kept growth in check.
The Market Online Video

Meeting the projected lithium and copper supply imbalance

CEO Tim Fernback discusses how Grid Battery Metals' (TSX:CELL) projects can help meet the projected lithium and copper supply imbalance.
doctor holding palm of hand out with bladder cancer sign

Latest data from bladder cancer study to propel future growth 

Theralase Technologies (TSXV:TLT) is developing small molecule drugs able to specifically target and destroy cancer cells.